PRN: Global Coronary Stents (Bare Metal, Drug-Eluting, Bioresorable) Market 2016-2021 - Focus on Lowering of ASP in Coronary Stents - Research and Markets

20/feb/2017 14:10:13 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Coronary Stents (Bare Metal, Drug-Eluting, Bioresorable) Market 2016-2021 - Focus on Lowering of ASP in Coronary Stents - Research and Markets

 
[20-February-2017]
 

DUBLIN, Feb 20, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Coronary Stents Market (Bare Metal, Drug-Eluting, Bioresorable): Analysis By Segment, By Region, By Country (2016-2021)" report to their offering.

Global Coronary Stents Market is forecasted to grow at a CAGR of 3.05% during 2016-2021F, on account of rising incidences of cardiovascular diseases globally leading to growing number of stent procedures.

Rising development of bioresorbable stents combined with the growing awareness towards cardiovascular risks in developing countries has resulted in the growth of coronary stents market. Cardiovascular diseases are witnessing growth on account of the rise in the lifestyle related diseases including obesity, diabetes, hypertension etc.

Among the types of coronary stents, market is expected to be driven by bioresorbable stents, mainly in the polylactic acid material. However, drug eluting stents will continue to generate major revenue while bare metal stents will further continue to decline.

While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure and rising focus on healthcare among the growing middle class population.

Scope of the Report

The report provides Segmentation by Stent Type:

- Bare Metal stents

- Drug-Eluting Stents

- Bioresorbable Stents

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

3.1. Bioresorbable Stents as the Future Market

3.2. Focus on Lowering of ASP in Coronary Stents

3.3. Opportunities in APAC Region

4. Global Coronary Stents Market: An Analysis

4.1. Product Overview

4.2. Global Coronary Stents Market

4.3. Global Coronary Stent Market, By Segments

4.4. Global Bare Metal Stents, By Value

4.5. Global Drug Eluting Stents, By Value

4.6. Global Bioresorbable Stents Market, By Segments

4.7. Global Coronary Stent Market, By Region

4.8. Coronary Stents: Pipeline Analysis

5. North America Coronary Stent Market: An Analysis

6. Europe Coronary Stent Market: An Analysis

7. APAC Coronary Stent Market: An Analysis

8. ROW Coronary Stent Market: An Analysis

9. Market Dynamics

9.1. Trends

9.2. Drivers

9.3. Challenges

10. Pricing Structure

11. Policy and Regulatory Landscape

12. M&A and Licensing Route to Coronary Stent Market

13. SWOT Analysis

14. Porter's Five Forces Model

15. Product Benchmarking

16. Company Profiles

16.1 Terumo Corporation

16.2 Boston Scientific

16.3 Stentys SA

16.4 MicroPort Scientific Corporation

16.5. Biotronik

16.6 Elixir Medical Corporation

16.7 Biosensors Inc.

16.8 Medtronic

16.9 Abbott Laboratories

16.10 Kyoto Medical Planning

For more information about this report visit http://www.researchandmarkets.com/research/scv9ql/global_coronary

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl